Cartesian Therapeutics
RNAC
RNAC
64 hedge funds and large institutions have $110M invested in Cartesian Therapeutics in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
5% more funds holding
Funds holding: 61 → 64 (+3)
Holders
64
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$37.7M | |
| 2 | +$5.96M | |
| 3 | +$5.76M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$3.22M |
| 5 |
YU
Yale University
New Haven,
Connecticut
|
+$1.61M |
Top Sellers
| 1 | -$8.23M | |
| 2 | -$3.07M | |
| 3 | -$2.43M | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$871K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$811K |